Subscribe
22 September 2017Americas

Video interview: Allen & Overy on CRISPR evolution

To evaluate how the CRISPR licensing landscape might evolve, parties need to analyse the current patent environment.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Video interview: Allen & Overy on the UPC and CRISPR
19 September 2017   The Unified Patent Court is likely to spark years of uncertainty and may even become part of the UK’s negotiations for Brexit.
article
Video interview: Canada prepares for PTE system
5 September 2017   The development of Canada’s exclusivity framework was the focus of a roundtable at Life Sciences Patent Network North America, hosted by LSPR in Boston.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
Video interview: Allen & Overy on the UPC and CRISPR
19 September 2017   The Unified Patent Court is likely to spark years of uncertainty and may even become part of the UK’s negotiations for Brexit.
article
Video interview: Canada prepares for PTE system
5 September 2017   The development of Canada’s exclusivity framework was the focus of a roundtable at Life Sciences Patent Network North America, hosted by LSPR in Boston.

More on this story

Americas
Video interview: Allen & Overy on the UPC and CRISPR
19 September 2017   The Unified Patent Court is likely to spark years of uncertainty and may even become part of the UK’s negotiations for Brexit.
article
Video interview: Canada prepares for PTE system
5 September 2017   The development of Canada’s exclusivity framework was the focus of a roundtable at Life Sciences Patent Network North America, hosted by LSPR in Boston.

More features

Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers